Table 1

Baseline patient characteristics

logEuroSCORE ≥20% mean±SD or n/N (%)
(n=890)
logEuroSCORE <20% mean±SD or n/N (%)
(n=789)
P value
Age (years)81.6±5.480.1±6.3<0.001
Female gender458/890 (51.5)444/789 (56.3)0.048
Cardiac history
 Prior MI207/884 (23.4)82/772 (10.6)<0.001
 Prior cardiac surgery*315/890 (35.4)107/788 (13.6)<0.001
 Prior stroke210/890 (23.6)54/788 (6.9)<0.001
Comorbidities
 AF414/890 (46.5)267/789 (33.8)<0.001
 Hypertension844/890 (94.8)738/789 (93.5)0.256
 CAD593/883 (67.2)374/772 (48.4)<0.001
 Mitral valve insufficiency (>II°)54/888 (6.1)19/785 (2.4)<0.001
 Porcelain aorta266/884 (30.1)212/773 (27.4)0.232
 Pulmonary hypertension362/889 (40.7)158/788 (20.1)<0.001
 COPD204/890 (22.9)140/789 (17.7)0.009
 Diabetes mellitus304/890 (34.2)214/789 (27.1)0.002
 Kidney insufficiency581/888 (65.4)379/789 (48.0)<0.001
Dialysis36/888 (4.1)10/789 (1.3)<0.001
NYHA class III or IV726/861 (84.3)579/741 (78.1)0.001
LVEF (%)49.9±13.957.4±10.3<0.001
Peak AV gradient (mm Hg)73.5±26.179.2±23.5<0.001
Mean AV gradient (mm Hg)45.3±17.149.5±15.7<0.001
STS score (%)11.8±10.18.0±8.3<0.001
LogEuroSCORE (%)34.5±13.012.6±4.3<0.001
  • *Not including percutaneous coronary intervention.

  • AF, atrial fibrillation; AV, aortic valve; CAD, coronary artery disease; COPD, chronic obstructive pulmonary disease; logEuroSCORE, logistic European System for Cardiac Operative Risk Evaluation; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NYHA, New York Heart Association; STS, Society of Thoracic Surgeons.